Jump to content

User:Catcus DeMeowwy

From Simple English Wikipedia, the free encyclopedia
(Redirected from User:Catcus DeMeowwy/)

Hopefully by tomorrow I will have everything done, to be able to get back to the surface (to cat: Inflammation)! :)

change source section

[change | change source]

https://commons.wikimedia.org/wiki/File:AS_trask.jpg[purge] (Link to file) (red link?)


Useful references and reliable sources (Wikiessay) https://en.wikipedia.org/wiki/Wikipedia:WikiProject_Medicine/Lists_of_pages/Non-articles

I, the copyright holder of this work, hereby publish it under the following license:

Impact frame (interesting wikicode)

[change | change source]

Showing impact data for Catcus DeMeowwy

Total edits
4,151
Total edits
Thanks received
5
Thanks received
Last edited 14 minutes ago
Last edited
Longest streak 13 days
Longest streak

Recent activity (last 60 days)

1,000 Edits
Feb 26
Apr 26
13,153 Views on articles edited
A line chart showing the total daily views for articles edited in the last 60 days.

Please enable JavaScript to view this component.

Licensing

[change | change source]

References ↑

McKenna KA, Fogleman CD (August 2021). "Dysmenorrhea". Am Fam Physician. 104 (2): 164–170. PMID 34383437. American College of Obstetricians and Gynecologists (Jan 2015). "FAQ046 Dynsmenorrhea: Painful Periods" (PDF). Archived (PDF) from the original on 27 June 2015. Retrieved 26 June 2015.


The heart (Anatomy of the human heart)

[change | change source]
Find more about
Heart
at Wikipedia's sister projects
Search Wiktionary Definitions from Wiktionary
Search Commons Media from Commons
Search Wikiquote Quotations from Wikiquote
Search Wikisource Source texts from Wikisource
Search Wikibooks Textbooks from Wikibooks
Search Wikiversity Learning resources from Wikiversity
Search Wikidata Data from Wikidata
Search Meta-Wiki Discussion from Meta-Wiki
Search MediaWiki Documentation from MediaWiki
  • General
Anatomy_of_the_arteries_of_the_human_body_-_descriptive_and_surgical,_with_the_descriptive_anatomy_of_the_heart_(1881)_(14764835715)
Anatomy_of_the_arteries_of_the_human_body_-_descriptive_and_surgical,_with_the_descriptive_anatomy_of_the_heart_(1881)_(14764835715)
(above) Anatomy of the arteries of the human body - descriptive and surgical, with the descriptive anatomy of the heart (1881)[1] (14764835715).jpg
  • (Surface (base) cont.)
    • The surface of Mars looks a bit like a heart (and an angel)
Perspective_view-_An_angel_and_heart_on_Mars_ESA22393107
Perspective_view-_An_angel_and_heart_on_Mars_ESA22393107
(above) a Perspective view- An angel and heart on Mars ESA22393107.jpeg (from [2])

(AI): The apex of the heart is the lowest, most pointed part of the heart, located at the inferolateral region of the left ventricle. It sits posterior to the left 5th intercostal space, typically about 9 cm from the median plane[3]. (en Wiki): The heart is cone-shaped, with its base positioned upwards and tapering down to the apex.[4]

The human heart is in the middle of the thorax, with its apex pointing to the left.
The human heart is in the middle of the thorax, with its apex pointing to the left.
(above) The human heart is in the middle of the thorax, with its apex pointing to the left.[5] (commons.png)

a sulcus (pl.: sulci) is a furrow or fissure (Latin fissura, pl.: fissurae), of which the heart has many:

They are not just in the heart but the brain too.

Rotating image of human brain, illustrating the lateral sulcus in the brain.


Medical_diagnosis_for_the_student_and_practitioner_(1922)_(14784496995)
Medical_diagnosis_for_the_student_and_practitioner_(1922)_(14784496995)
(above) Medical diagnosis for the student and practitioner (1922)[6] (14784496995).jpg
(above) (text appearing before the image): It maycease for short periods, moreover, to beat at all, in which case syncopalattacks may occur and thus round out the classical Adams-Stokessyndrome. The Pace Maker of the Heart.—Whence come the rhythmic impulses whichinduce coordinate contraction of the auricles and ventricles? There is a normal point of maximum irritability represented by a networkof specialized muscle cells richly supplied with nerves and imbedded in theupper anterior end of the sulcus terminalis, which sulcus runs from the in-ferior vena cava to the junction of the superior vena cava with the rightauricular appendix. *W. H. Gaskell of Cambridge University, England, actually demonstrated bothmyogenic conduction and heart block in the frog and tortoise in the year 1883. THE EXAMINATION OF THE HEART 467 This is the sino-auriciilar node of Keith and Flack which, from its stationin the wall of the right auricle at the mouth of the superior vena cava, normally initiates each contraction of the heart.

Sulcus runs from the inferior vena cava to the junction of the superior vena cava with the right auricular appendix in this image.

  • (Sulci cont.)
    • Sulci is continued in a following section outside of general (surface).
  • (General cont.)
    • Borders

The two borders of the heart are right border of heart and left margin of heart (en Wiki).

Right border of heart
Details
Identifiers
Latinmargo dexter cordis
Anatomical terminology
Gray492
Gray492
(above) Sternocostal surface of heart. (Right margin visible but not labeled.) (1982)[7][8] (gray492.png)
Left border of heart
Details
Identifiers
Latinmargo obtusus
Anatomical terminology
Anatomical structures captured from the app 3D Heart Anatomy
Anatomical structures captured from the app 3D Heart Anatomy
(above) left border of heart.
  • (General cont.)
    • Base section end / (General) Internal:
    • Atria (Atrium)

deleted information

[change | change source]
  • backup:
Michellamine (en.Wiki) from user Jshepeck (en. Wiki) user page/Michellamine
Catcus DeMeowwy
Names
IUPAC name
(1R,3R,1’R,3’R)-5,5’-(1,1’-dihydroxy-8,8’-dimethoxy-6,6’-dimethyl-2,2’-binaphthalene-4,4’-diyl)bis(1,3-dimethyl-1,2,3,4-tetrahydroisoquinoline-6,8-diol)
Identifiers
3D model (JSmol)
ChemSpider
Properties
C46H48N2O8
Molar mass 756.882
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
Tracking categories (test):


Michellamine is an atropisomeric alkaloid which has been found as a strong anti-HIV enzyme. It was discovered in the leaves of the Ancistrocladus korupensis which is a member of the Triphyophyllum peltatum found in Cameroon.[9] There are 3 michellamines represented as A, B, and C, however, Michellamine B is the most active against the NID-DZ strain of HIV-2.[10]

Occurance

Michellamine A and B alkaloids are found to naturally occur in the leaves of the Ancistrocladus korupensis which is a member of the Triphyophyllum peltatum found in Cameroon. Bioactive chemical substances including alkaloids, tannins, and saponin are found in several plants in their roots, leaves, stems, flowers, or bark. Therapeutic chemicals have been found in various plants to treat diseases such as malaria, diabetes, and cancers.[11]

Synthesis

There are 2 methods explored to synthesize Michellamines A and B. The first one, originally synthesized in 1994, is a retrosynthesis that leads to a biomimetic pathway that uses the construction of naphthalene/isoquinoline bonds before the naphthalene/naphthalene axis. The second method, originally synthesized only a few montes after the first method, is a complementary pathway that would use the naphthalene/naphthalene axis after it is created and add the 2 isoquinoline moieties.[12]

Medical Use

The main use of Michellamines are in anti-HIV medications. It is found to inhibit viral replication of the Protein kinase C and virus-induced cellular fusion. It has a broad range of effectiveness across most HIV strains and especially in the strain HIV-2, which is found primarily in and around Cameroon.[13]

References

  1. ↑ https://archive.org/stream/anatomyofarterie00powe/anatomyofarterie00powe#page/n18/mode/1up
  2. ↑ https://www.esa.int/ESA_Multimedia/Images/2020/12/Perspective_view_An_angel_and_heart_on_Mars
  3. ↑ https://www.kenhub.com/en/library/anatomy/apex-of-the-heart
  4. ↑ http://cnx.org/content/m46676/latest/?collection=col11496/latest
  5. ↑ "Gray's Anatomy of the Human Body – 6. Surface Markings of the Thorax". Bartleby.com. Archived from the original on 20 November 2010. Retrieved 2010-10-18.
  6. ↑ https://archive.org/stream/medicaldiagnosi00gree/medicaldiagnosi00gree#page/n494/mode/1up
  7. ↑ http://www.bartleby.com/107/
  8. ↑ http://www.bartleby.com/107/illus492.html
  9. ↑ Schlauer, Jan; Rückert, Markus; Wiesen, Birgit; Herderich, Markus; Assi, Laurent Aké; Haller, René D.; Bär, Sabine; Fröhlich, Kai-Uwe; Bringmann, Gerhard (1). "Characterization of Enzymes fromAncistrocladus(Ancistrocladaceae) andTriphyophyllum(Dioncophyllaceae) Catalyzing Oxidative Coupling of Naphthylisoquinoline Alkaloids to Michellamines". Archives of Biochemistry and Biophysics. 350 (1): 87–94. doi:10.1006/abbi.1997.0494. PMID 9466824. {{cite journal}}: Check date values in: |date= and |year= / |date= mismatch (help); Unknown parameter |month= ignored (help)
  10. ↑ Zhang, Heping; Zembower, David E.; Chen, Zhidong (NaN undefined NaN). "Structural analogues of the michellamine anti-HIV agents. Importance of the tetrahydroisoquinoline rings for biological activity". Bioorganic & Medicinal Chemistry Letters. 7 (20): 2687–2690. doi:10.1016/S0960-894X(97)10057-9. {{cite journal}}: Check date values in: |date= and |year= / |date= mismatch (help); Unknown parameter |month= ignored (help)
  11. ↑ Okigbo, R. N. (February 2009). [[[:Template:Predatory]] "Advances in selected medicinal and aromatic plants"]. Journal of Medicinal Plants Research. 3 (2): 86–95. Retrieved April 6, 2011. {{cite journal}}: Check |url= value (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)CS1 maint: date and year (link)
  12. ↑ Bringmann, Gerhard; Götz, Roland; Keller, Paul A.; Walter, Rainer; Boyd, Michael R.; Lang, Fengrui; Garcia, Alberto; Walsh, John J.; Tellitu, Imanol; Bhaskar, K. Vijaya; Kelly, T. Ross (NaN undefined NaN). "A Convergent Total Synthesis of the Michellamines". The Journal of Organic Chemistry. 63 (4): 1090–1097. doi:10.1021/jo971495m. {{cite journal}}: Check date values in: |date= and |year= / |date= mismatch (help); Unknown parameter |month= ignored (help)
  13. ↑ White, E.Lucile; Chao, Wan-ru; Ross, Larry J.; Borhani, David W.; Hobbs, Peter D.; Upender, Velaparthi; Dawson, Marcia I. (1). "Michellamine Alkaloids Inhibit Protein Kinase C". Archives of Biochemistry and Biophysics. 365 (1): 25–30. doi:10.1006/abbi.1999.1145. PMID 10222035. {{cite journal}}: Check date values in: |date= and |year= / |date= mismatch (help); Unknown parameter |month= ignored (help)
[ [Category:Alkaloids]]
  • Backup:
Jean-Pierre Lecocq (en. Wiki) from User Grey_Geezer (en.Wiki) user page/Genpool
Jean-Pierre Lecocq (17 July 1947 – 20 January 1992) was a Belgian molecular biologist and entrepreneur.

Education

Lecocq was born in Gosselies/Charleroi but grew up in Nivelles. In 1965 he received a scholarship to study Chemistry at the the Free University of Brussels. In 1969 he graduated with honors (avec grande distinction). Starting in 1969, he worked on his doctoral thesis in the laboratory of Prof. René Thomas, Département de Biologie Moléculaire, on the interactions between a prokaryote (Escherichia coli) and a virus (bacteriophage lambda). He identified new bacterial genes, which lead to bacterial lysogenic cycle and lysis and he analyzed mutants of RNA polymerase. From 1974 to 1975 Lecocq was drafted into the military, but returned to research to finish his PhD in 1975 with summa cum laude (la plus grande distinction). Until early 1977, he continued working at the Free University in Brussels as a post-doc (Chargé de Recherche) with short research stays in the USA (Madison, Wisconsin) and Canada (Laval University, Quebec).

Professional career

From 1977 to 1980, in the early years of the rapidly developing genetic engineering, Lecocq was project manager in the Department of Genetics of the pharmaceutical company SmithKline RIT, in Rixensart, Belgium, where he set up a molecular biology laboratory and directed the research on vaccines against enteropathogenic E. coli strains, and hepatitis B virus.

In 1980 he became Scientific Director of Transgène, one of the first biotech companies in France, which was founded in Strasbourg in 1979 by the initiative of Prof. Pierre Chambon and Dr. Philippe Kourilsky, the goal beeing to develop new technologies in biomedical research for industrial applications. In 1984, Lecocq became Vice President and in 1990 President of Transgène.

After Transgène was acquired in 1991 by the Mérieux group, Lecocq also became Corporate Director of Research and Development of the Pasteur-Merieux-Connaught Group, based in Lyon.

Jean-Pierre Lecocq died at age 44 in the crash of Air Inter Flight 148 on 20 January 1992 at Mont Sainte-Odile, Alsace. He is survived by his wife Mireille and two children.

Research

From 1980 until 1992 Lecocq established French and international collaborations between Transgène, academic institutions and industry.
Under his leadership secretory and non-secretory expression systems for the production of recombinant proteins in E. coli, Saccharomyces cerevisiae, Baculovirus and mammalian cells in cell culture were developed and recombinant virus technology was established. A Hybridoma Laboratory provided for the development of monoclonal antibodis for analyses ((ELISA) and immunoaffinity chromatography. Conventional as well as HPLC methods for downstream purification and analysis of the produced peptides, proteins and glycoproteins were established.
These technologies have been applied, among others, to the following projects: a new concept based on vaccinia virus for a rabies vaccine in the wild (Raboral, in November 1991 awarded with the Rhone Poulenc Prize for Innovation and used in several countries for the vaccination of foxes, and raccoons), recombinant versions of blood clotting factor VIII|factor VIII and Factor IX for the treatment of hemophilia A on behalf of the French blood transfusion service CNTS; vaccine candidates for schistosomiasis, toxoplasmosis and babesia canis; recombinant hirudin, α-1-antitrypsin, gamma-interferon and interleukins, and variants thereof, construction of virtually all recombinant proteins of HIV-1, HIV-2 and SIV for mechanistic studies and applications in diagnosis, and immunization; characterization of α-thrombin receptor, mechanisms of Cystic Fibrosis.

Publications

Between 1970 and 1991 Jean-Pierre Lecocq published 130 papers, 15 additional publications about subjects and projects initiated by Lecocq appeared from 1992 until 1995 postum.
In the following a selection of representative publications is listed:

  • J.P. Lecocq (doctoral thesis) Étude génétique et biochimique de la régulation de la transcription Dépt. de Biologie Moléculaire, Université Libre de Bruxelles (1975)
  • J.P. Lecocq, C. Dambly, R. Lathe, C. Babinet, A. Bailone, R. Devoret, A.M. Gathoye, H. Garcia, M. Dewilde and T. Cabezon Nomenclature and location of bacterial mutations modifying the frequency of lysogenisation of E.coli by lambdoïd phages Molec. Gen. Genet. 145, 63-64 (1976)
  • J.P. Lecocq, M. Zubowski and R. Lathe Cloning and expression of viral antigens in Escherichia coli and other microorganisms in: "Methods in Virology" (1984), 7, 121-172, K. Maramorosch, H. Koprowski, eds, Academic Press Inc, Orlando , Florida.
  • M. Courtney, S. Jallat, L.H. Tessier, A. Benavente, R.G. Crystal and J.P. Lecocq Synthesis in E. coli of alpha1-antitrypsin variants of therapeutic potential emphysema and thrombosis Nature 313, 149-151 (1985)
  • H. de la Salle, W. Altenburger, R. Elkaim, K. Dott, A. Dieterlé, R. Drillien, J.P. Cazenave, P. Tolstoshev and J.P. Lecocq Active gamma-carboxylated human factor IX expressed using recombinant DNA techniques Nature 316, 268-270 (1985)
  • R.P. Harvey, E. Degryse, L. Stefanie, F. Schamber, J.P. Cazenave, M. Courtney, P. Tolstoshev and J.P. LecocQ Clonig and expression of a cDNA coding for the anticoagulant hirudin from the bloodsucking leech, hirudo medicinalis Proc. Natl. Acad. Sci. USA, 83, 1084-1088 (1986)
  • A. Capron, R. Pierce, J.M. Balloul, J.M. Grzych, C. Dissous, P. Sondermeyer and J.P. Lecocq Protective antigens in experimental schistosomiasis Acta Tropica 44, 63-69 (1987)
  • G. Rautmann, M.P. Kieny, R. Brandely, K. Dott, M. Girard, L. Montagnier and J.P. Lecocq HIV-1 core proteins expressed from recombinant vaccinia viruses AIDS Res. Hum. Retroviruses (1989) 5, 147-57.
  • M.P. Kieny, J.P. Lecocq, M. Girard, Y. Rivière, L. Montagnier and R. Lathe Tailoring the human immunodeficiency virus envelope glycoprotein to improve immunogenicity in: Vaccines 89, R.A. Lerner, H. Ginsberg, R.M. Chanock, F. Brown, Cold Spring Harbor Laboratory, 177-183 (1989)
  • J.P. Van Eendenburg, M. Yagello, M. Girard, M.P. Kieny, J.P. Lecocq, E. Muchmore, P.N. Fultz, Y. Rivière, L. Montagnier and J.C. Gluckman Cell-mediated immune proliferative responses to HIV-1 of chimpanzees vaccinated with different vaccinia recombinant viruses AIDS Res. Hum. Retroviruses (1989) 5, 41-50.
  • T. Faure, A. Pavirani, P. Meulien, H. de la Salle, G. Mignot, H. van de Pol, M. Courtney and J.P. Lecocq Stable expression of coagulation factors VIII and IX in recombinant chinese hamster ovary cells Advances in Animal Cell Biology and Technology for Bioprocesses (1989), R.E. Spier, J.B. Griffiths, J. Stephenne, P.J. Crooy, Butterworths, England, 481-487.
  • M.F. Cesbron-Delauw, B. Guy, G. Torpier, R.J. Pierce, G. Lenzen, J.Y. Cesbron, H. Charif, P. Lepage, F. Darcy, J.P. Lecocq et al. Molecular characterization of a 23-kilodalton major antigen secreted by Toxoplasma gondii Proc. Natl. Acad. Sci. USA, 86 , 7537-7541 (1989)
  • B. Brochier, M.P. Kieny, F. Costy, P. Coppens, B. Bauduin, J.P. Lecocq, B. Languet, G. Chappuis, P. Desmettre, K. Afiademanyo, R. Libois and P.P. Pastoret Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine Nature 354, 520-522 (1991)
  • M.A. Rosenfeld, W. Siegfried, K. Yoshimura, K. Yoneyama, M. Fukayama, L.E. Stier, P.K. Paakko, P. Gilardi, L.D. Stratford-Perricaudet, M. Perricaudet, S. Jallat, A. Pavirani, J.P. Lecocq and R.G. Crystal Adenovirus-Mediated transfer of a recombinant alpha-1-antitrypsin gene to the lung epithelium in vivo Science, 252, 431-434 (1991)
  • U.B. Rasmussen, V. Vouret-Craviari, S. Jallat, Y. Schlesinger, G. Pages, A. Pavirani, J.P. Lecocq, J. Pouyssegur and E. Van Obberghen-Schilling E. cDNA cloning and expression of a hamster alpha-thrombin receptor coupled to Ca2+ mobilization FEBS Lett. 288 , 123-128 (1991)
  • J.M. Reichart, I. Petit, M. Legrain, J.L. Dimarq, E. Keppi, J.P. Lecocq, J.A. Hoffmann and T. Achstetter Expression and Secretion in Yeast of Active Insect Defensin, an Inducible Antibacterial Peptide from the Fleshfly Phormia terranovae Invert. Reprod. and Dev., 21, 15-24 (1992)
  • M.A. Rosenfeld, K. Yoshimura, B.C. Trapnell, K. Yoneyama, E.R. Rosenthal, W. Dalemans, M. Fukayama, J. Bargon, L.E. Stier, L.D. Stratford-Perricaudet, M. Perricaudet, W.B. Guggino, A. Pavirani, J.P. Lecocq and R.G. Crystal In vivo Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator Gene to Airway Epithelium Cell, 68, 143-155 (1992)

Editorial boards

Lococq was on the editorial boards of the following journals:

Memberships

Lecocq was a member of the following organizations:

  • Société Belge de Biochimie since 1970
  • European Molecular Biology Organization(EMBO)since 1985
  • Conseil Scientifique des Institut National de la Recherche Agronomique (INRA) since 1986
  • Advisor of the World Health Organization (WHO) in Geneva since 1986
  • Comité National de Biochimie: Section des Représentants Français des Industries Biologiques et Biochimiques since 1986
  • Conseil Scientifique de l'Université Louis Pasteur, Strasbourg since 1986
  • Conseil Scientifique de l'Association Française de Médecine Préventive since 1986
  • Comité d'Orientation de la Délégation Régionale de l'ANVAR France since 1986
  • Comité Académique des Applications de la Science (CADAS) since 1988

Fondation Jean-Pierre Lecocq

To honor the achievements and the person, in 1992 the Fondation Jean-Pierre Lecocq was created, which since 1994 (and until the year 2020) awards a bi-annual prize for "new and significant research achievements in molecular biology and their application".

Bibliography

  • Orbituary in Molecular Microbiology (1992) 6 (11), S. 1577-1578
  • Orbituary in Gene (1992) 118 (1), S. 1-4
  • Archive of Transgène SA, Boulevard Gonthier d’Andernach, Parc d’Innovation, F-67405 Illkirch Graffenstaden Cedex, France.
{{Persondata |NAME= Lecocq, Jean-Pierre |ALTERNATIVE NAMES= |SHORT DESCRIPTION= [[Belgium|Belgian]] [[Molecular Biology|molecular biologist]] and [[Entrepreneur|entrepreneur]] |DATE OF BIRTH= 1947-07-17 |PLACE OF BIRTH= [[Gosselies]], [[Belgium]] |DATE OF DEATH= 1992-01-20 |PLACE OF DEATH= [[Mont Sainte-Odile]], [[Alsace]] }} {{DEFAULTSORT:Lecocq, Jean-Pierre}} [[Category:Chemist]] [[Category:Molecular Biologist]] [[Category:Virologist]] [[Category:Entrepreneur (France)]] [[Category:HIV/AIDS researchers]] [[Category:Belgian]] [[Category:1947 births]] [[Category:1992 deaths]] [[Category:Man]] {{Personendaten |NAME=Lecocq, Jean-Pierre |ALTERNATIVNAMEN= |KURZBESCHREIBUNG=belgischer Molekularbiologe und Unternehmer |GEBURTSDATUM=17. Juli 1947 |GEBURTSORT=Gosselies |STERBEDATUM=20. Januar 1992 |STERBEORT=Mont Sainte-Odile }}
  • archive
==Copyright==

Still follow up on this

"STD incidence rates remain high in most of the world, despite diagnostic and therapeutic advances that can rapidly render patients with many STDs noninfectious and cure most. In many cultures, changing sexual morals and oral contraceptive use have eliminated traditional sexual restraints, especially for women, and both physicians and patients have difficulty dealing openly and candidly with sexual issues. Additionally, development and spread of drug-resistant bacteria (e.g., penicillin-resistant gonococci) makes some STDs harder to cure. The effect of travel is most dramatically illustrated by the rapid spread of the AIDS virus (HIV-1) from Africa to Europe and the Americas in the late 1970s.[1]

Commonly reported prevalences of STIs among sexually active adolescent girls both with and without lower genital tract symptoms include chlamydia (10–25%), gonorrhea (3–18%), syphilis (0–3%), Trichomonas vaginalis (8–16%), and herpes simplex virus (2–12%).[source?] Among adolescent boys with no symptoms of urethritis, isolation rates include chlamydia (9–11%) and gonorrhea (2–3%).[source?] "

May be from [1] Doc James (talk · contribs · email) 23:23, 27 January 2017 (UTC)

Yup a copyright problem. Doc James (talk · contribs · email) 03:56, 28 January 2017 (UTC)
Yes, it was added in this edit in 2006. The editor who added it also included a link to that source, so it isn't a case of reverse copyvio. Hut 8.5 21:51, 9 February 2017 (UTC)

References

  1. ↑ Mary-Ann Shafer; Anna-Barbara Moscicki (2006). "Sexually Transmitted Infections, 2006": 1–8. {{cite journal}}: Cite journal requires |journal= (help)
thankyou @Doc James :3

rollback / edit war

[change | change source]

edits

Check out https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
At one point the article the editor had the cause of death ranking wrong (and uses future predictions insread of past information). This is cited
Those are terrible bulletpoints which could be shortened down a lot. One of the bullet points I edited is the issue, which saw the whole article rolled back.
The "jargon" is used in brackets () with links to other wikipedia pages. This article rollback put information back in the article about the circulation which is wrong. W;ChangingUsername (talk) 18:03, 22 May 2024 (UTC)
Respectfully we're not a medical website, Anywho go to WP:Simple talk as others may disagree with me or may agree and either way will be able to help you better than I can, Thanks, –Davey2010Talk 18:07, 22 May 2024 (UTC)
Added. https://simple.m.wikipedia.org/wiki/Wikipedia:Simple_talk#Stroke_page in case you want to take part in the discussion.
And (reapectfully) the rules say the article needs to be written simply, not that it needs to be less detailed or cover information worse. Roll back your article properly if youre going to try and make it entirely your own

And the FAST memory aid should be remembered by everyone to help spot strokes. W;ChangingUsername (talk) 18:19, 22 May 2024 (UTC)

Never once said it needs to be less detailed or cover worse information, I'm simply saying your edits aren't an improvement over what is there. Thanks. –Davey2010Talk 18:23, 22 May 2024 (UTC)

Rockefeller family

[change | change source]

Tens of thousands of characters deleted (changes page revision link) archived[1] with (web).archive.org.


[change | change source]
  1. ↑ "Rockefeller family: Difference between revisions - Simple English Wikipedia, the free encyclopedia". web.archive.org. 2025-04-25. Retrieved 2025-04-25.
Retrieved from "https://simple.wikipedia.org/w/index.php?title=User:Catcus_DeMeowwy&oldid=10216110"